|

Validation of Belun Ring Gen3 Deep Learning Algorithms With Subxiphoid Body Sensor

RECRUITINGN/ASponsored by Belun Technology Company Limited
Actively Recruiting
PhaseN/A
SponsorBelun Technology Company Limited
Started2024-07-19
Est. completion2026-03-31
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
Locations2 sites

Summary

Hypothesis: BR's Gen3 DL algorithms, combined with its subxiphoid body sensor, can accurately diagnose OSA, categorize its severity, identify REM OSA and supine OSA, and detect central sleep apnea (CSA). Primary Objective: To rigorously evaluate the overall performance of the BR with Gen3 DL Algorithms and Subxiphoid Body Sensor in assessing SDB in individuals referred to the sleep labs with clinical suspicion of sleep apnea and a STOP-Bang score \> 3, by comparing to the attended in-lab PSG, the gold standard. Secondary Objectives: To determine the accuracy of BR sleep stage parameters using the Gen3 DL algorithms by comparing to the in-lab PSG; To assess the accuracy of the BR arrhythmia detection algorithm; To assess the impact of CPAP on HRV (both time- and frequency-domain), delta HR, hypoxic burden, and PWADI during split night studies; To assess if any of the baseline HRV parameters (both time- and frequency-domain), delta heart rate (referred to as Delta HR), hypoxic burden, and pulse wave amplitude drop index (PWADI) or the change of these parameters may predict CPAP compliance; To evaluate the minimum duration of quality data necessary for BR to achieve OSA diagnosis; To examine the performance of OSA screening tools using OSA predictive AI models formulated by National Taiwan University Hospital (NTUH) and Northeast Ohio Medical University (NEOMED).

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Provision of signed informed consent form.
* Clinically assessed and suspicious for OSA with a STOP-Bang score ≥ 3.

Exclusion Criteria:

* Full night PAP titration study.
* On home O2, noninvasive ventilator, diaphragmatic pacing, or any form of a nerve stimulator.
* Having atrial fibrillation-flutter, pacemaker/defibrillator, left ventricular assist device (LVAD), or status post cardiac transplantation.
* Recent hospitalization or recent surgery in the past 30 days.
* Unstable cardiopulmonary status on the night of the study judged to be unsafe for sleep study by the sleep tech and/or the on-call sleep physician.

If a participant did not sleep for at least 4 hours of technically valid sleep based on the Belun Ring method for diagnostic assessments, or a minimum of 3 hours of technically valid sleep during the diagnostic phase of a split-night study, the patient will be excluded from statistical analysis.

Conditions4

ArrhythmiaHeart DiseaseSleep ArchitectureSleep-Disordered Breathing

Locations2 sites

UH Geauga Health Center Services
Chardon, Ohio, 44024
Ambrose A Chiang, MD
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106
Ambrose A Chiang, MD216-791-3800Ambrose.Chiang@UHhospitals.org

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.